-transparent.png){kind=logo}
Platelet activation (cytosolic [Ca2+] increase, aggregation and ATP secretion) was induced with A1F-4. This agent presumably interacts with a G protein which appears to mediate the coupling of the receptors for Ca mobilizing hormones and phospholipase C. All the A1F-4 evoked responses were inhibited by treatment with forskolin or prostacyclin, agents known to increase cellular cAMP. Thus the G protein-phospholipase C system appears to be the site of cAMP inhibition. Unexpectedly forskolin and prostacyclin also inhibited secretion and aggregation induced by the activators of protein kinase C, diglyceride and phorbol ester, suggesting that cAMP can also inhibit directly the protein kinase C dependent responses.
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
May 1987,
The Biochemical journal,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
February 1989,
The Biochemical journal,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
October 1989,
The American journal of physiology,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
June 1997,
The Journal of biological chemistry,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
August 1992,
European journal of pharmacology,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
October 2013,
Zhongguo shi yan xue ye xue za zhi,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
October 2011,
FEBS letters,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
June 1990,
The Biochemical journal,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
April 1986,
Biochemical and biophysical research communications,
M G Doni, and
R Deana, and
S Bertoncello, and
F Zoccarato, and
A Alexandre
June 1999,
Circulation,
